Enhancing Trauma Care Through Geospatial Strategies: Tailored Approaches to a Worldwide Challenge
-
By
-
Michael K. Dalton
-
Molly P. Jarman
-
September 29, 2026
By
Michael K. Dalton
Molly P. Jarman
September 29, 2026
by Michael K. Dalton, Molly P. Jarman
September 29, 2026
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026
"One of the most tedious parts ... is at the end of surgery when we’re waiting for the team to count the instruments to make sure we didn’t lose one."
by Meg Barbor
September 28, 2026